Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhengzheng Xia

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annals of Translational Medicine|January 25, 2021
The effect of proton pump inhibitor uses on outcomes for cancer patients treated with immune checkpoint inhibitors: a meta-analysisChao Li, Zhengzheng Xia, Anna Li, et al.
Discover Oncology|April 25, 2025
ATP6AP1 drives pyroptosis-mediated immune evasion in hepatocellular carcinoma: a machine learning-guided therapeutic targetLei Tang, Xiyue Wang, Zhengzheng Xia, et al.
Molecules (Basel, Switzerland)|August 14, 2025
Oxygen-Vacancy Engineered SnO<sub>2</sub> Dots on rGO with N-Doped Carbon Nanofibers Encapsulation for High-Performance Sodium-Ion BatteriesYue Yan, Bingxian Zhu, Zhengzheng Xia, et al.
The Review of Scientific Instruments|March 3, 2017
Angles-centroids fitting calibration and the centroid algorithm applied to reverse Hartmann testZhu Zhao, Mei Hui, Zhengzheng Xia, et al.
Infectious Diseases of Poverty|September 22, 2023
Hepatitis B reactivation in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysisZhengzheng Xia, Jianyu Zhang, Wenjun Chen, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 12, 2024
Cost-effectiveness comparison of dalpiciclib and abemaciclib combined with an aromatase inhibitor as first-line treatment for HR+/HER2- advanced breast cancerJuan Hong, Tujia Chen, Lihui Ouyang, et al.
Frontiers in Oncology|December 20, 2024
Pembrolizumab versus sintilimab in patients with advanced NSCLC: a retrospective multicenter study with propensity-score matching analysisZhengzheng Xia, Juan Hong, Xiangyang Yu, et al.
Journal of Colloid and Interface Science|November 29, 2020
Reinforced atomically dispersed FeNC catalysts derived from petroleum asphalt for oxygen reduction reactionQingshan Zhao, Xiaojie Tan, Tianwen Ma, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annals of Translational Medicine|January 25, 2021
The effect of proton pump inhibitor uses on outcomes for cancer patients treated with immune checkpoint inhibitors: a meta-analysisChao Li, Zhengzheng Xia, Anna Li, et al.
Discover Oncology|April 25, 2025
ATP6AP1 drives pyroptosis-mediated immune evasion in hepatocellular carcinoma: a machine learning-guided therapeutic targetLei Tang, Xiyue Wang, Zhengzheng Xia, et al.
Molecules (Basel, Switzerland)|August 14, 2025
Oxygen-Vacancy Engineered SnO<sub>2</sub> Dots on rGO with N-Doped Carbon Nanofibers Encapsulation for High-Performance Sodium-Ion BatteriesYue Yan, Bingxian Zhu, Zhengzheng Xia, et al.
The Review of Scientific Instruments|March 3, 2017
Angles-centroids fitting calibration and the centroid algorithm applied to reverse Hartmann testZhu Zhao, Mei Hui, Zhengzheng Xia, et al.
Infectious Diseases of Poverty|September 22, 2023
Hepatitis B reactivation in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysisZhengzheng Xia, Jianyu Zhang, Wenjun Chen, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 12, 2024
Cost-effectiveness comparison of dalpiciclib and abemaciclib combined with an aromatase inhibitor as first-line treatment for HR+/HER2- advanced breast cancerJuan Hong, Tujia Chen, Lihui Ouyang, et al.
Frontiers in Oncology|December 20, 2024
Pembrolizumab versus sintilimab in patients with advanced NSCLC: a retrospective multicenter study with propensity-score matching analysisZhengzheng Xia, Juan Hong, Xiangyang Yu, et al.
Journal of Colloid and Interface Science|November 29, 2020
Reinforced atomically dispersed FeNC catalysts derived from petroleum asphalt for oxygen reduction reactionQingshan Zhao, Xiaojie Tan, Tianwen Ma, et al.
Pageof 1